InsidersTradesSigma
Total declarations
Company
▲ Purchases (7 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
7
Disclosed sells
0
T+90 hit rate
25%
T+90 mean return
+0.5%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Montalbano John S., Director. Insider active across 1 company, notably AbCellera Biologics Inc.. Cumulatively, 7 filings have been recorded. Split: 7 buys · 0 sell. Total volume traded: €684k. Activity tracked since 16 August 2021. The latest transaction was disclosed on 10 March 2025 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
25,000 shares@ US$2.307.7% of flowCommon SharesSEC:0001628280-25-011750:0
Canonical exit: 8 Jun 2025 (T+90)
60,000 shares@ US$2.342819.0% of flowCommon SharesSEC:0001628280-25-011254:0
Canonical exit: 4 Jun 2025 (T+90)
20,000 shares@ US$4.6412.6% of flowCommon SharesSEC:0001703057-23-000042:0
Canonical exit: 4 Feb 2024 (T+90)
10,000 shares@ US$8.540.0062% mcap18.6% of flowCommon SharesSEC:0001209191-22-016327:0
Canonical exit: 2 Jun 2022 (T+90)
20,000 shares@ US$9.050.013% mcap39.0% of flowCommon SharesSEC:0001209191-22-015227:0
Canonical exit: 30 May 2022 (T+90)
6,000 shares@ US$17.2312.8% of flowCommon SharesSEC:0001209191-21-051985
Canonical exit: 14 Nov 2021 (T+90)
6,000 shares@ US$17.230.0070% mcap21.2% of flowCommon SharesSEC:0001209191-21-051985:0
Canonical exit: 14 Nov 2021 (T+90)
7 of 7 declarations
About Montalbano John S.
John S. Montalbano is a Board Member at AbCellera Biologics Inc. He is involved in overseeing the company's activities and strategic direction. With his experience in biotechnology, he contributes to the company's growth and innovation.
